162 related articles for article (PubMed ID: 32622980)
1. Exploring impact of supersaturated lipid-based drug delivery systems of celecoxib on in vitro permeation across Permeapad
Ilie AR; Griffin BT; Brandl M; Bauer-Brandl A; Jacobsen AC; Vertzoni M; Kuentz M; Kolakovic R; Holm R
Eur J Pharm Sci; 2020 Sep; 152():105452. PubMed ID: 32622980
[TBL] [Abstract][Full Text] [Related]
2. Toward simplified oral lipid-based drug delivery using mono-/di-glycerides as single component excipients.
Ilie AR; Griffin BT; Vertzoni M; Kuentz M; Cuyckens F; Wuyts K; Kolakovic R; Holm R
Drug Dev Ind Pharm; 2020 Dec; 46(12):2051-2060. PubMed ID: 33124918
[TBL] [Abstract][Full Text] [Related]
3. Exploring precipitation inhibitors to improve in vivo absorption of cinnarizine from supersaturated lipid-based drug delivery systems.
Ilie AR; Griffin BT; Vertzoni M; Kuentz M; Kolakovic R; Prudic-Paus A; Malash A; Bohets H; Herman J; Holm R
Eur J Pharm Sci; 2021 Apr; 159():105691. PubMed ID: 33359616
[TBL] [Abstract][Full Text] [Related]
4. Do Phospholipids Boost or Attenuate Drug Absorption? In Vitro and In Vivo Evaluation of Mono- and Diacyl Phospholipid-Based Solid Dispersions of Celecoxib.
Jacobsen AC; Ejskjær L; Brandl M; Holm R; Bauer-Brandl A
J Pharm Sci; 2021 Jan; 110(1):198-207. PubMed ID: 32827494
[TBL] [Abstract][Full Text] [Related]
5. Digestion is a critical element for absorption of cinnarizine from supersaturated lipid-based type I formulations.
Paulus F; Bauer-Brandl A; Stappaerts J; Holm R
Eur J Pharm Sci; 2024 Jan; 192():106634. PubMed ID: 37951315
[TBL] [Abstract][Full Text] [Related]
6. Absorption of cinnarizine from type II lipid-based formulations: Impact of lipid chain length, supersaturation, digestion, and precipitation inhibition.
Paulus F; Holm R; Stappaerts J; Bauer-Brandl A
Eur J Pharm Sci; 2024 Jun; 197():106765. PubMed ID: 38608735
[TBL] [Abstract][Full Text] [Related]
7. Supersaturated lipid-based drug delivery systems - exploring impact of lipid composition type and drug properties on supersaturability and physical stability.
Ilie AR; Griffin BT; Kolakovic R; Vertzoni M; Kuentz M; Holm R
Drug Dev Ind Pharm; 2020 Mar; 46(3):356-364. PubMed ID: 31975613
[No Abstract] [Full Text] [Related]
8. Supersaturated polymeric micelles for oral cyclosporine A delivery.
Yu H; Xia D; Zhu Q; Zhu C; Chen D; Gan Y
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1325-36. PubMed ID: 23954511
[TBL] [Abstract][Full Text] [Related]
9. The Influence of Solidification on the in vitro Solubilisation of Blonanserin Loaded Supersaturated Lipid-Based Oral Formulations.
Møller A; Schultz HB; Meola TR; Müllertz A; Prestidge CA
Eur J Pharm Sci; 2021 Feb; 157():105640. PubMed ID: 33189902
[TBL] [Abstract][Full Text] [Related]
10. Supersaturated Silica-Lipid Hybrid Oral Drug Delivery Systems: Balancing Drug Loading and In Vivo Performance.
Schultz HB; Kovalainen M; Peressin KF; Thomas N; Prestidge CA
J Pharmacol Exp Ther; 2019 Sep; 370(3):742-750. PubMed ID: 30552294
[TBL] [Abstract][Full Text] [Related]
11. Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
McEvoy CL; Trevaskis NL; Feeney OM; Edwards GA; Perlman ME; Ambler CM; Porter CJH
Mol Pharm; 2017 Dec; 14(12):4525-4538. PubMed ID: 29076741
[TBL] [Abstract][Full Text] [Related]
12. An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations.
Anby MU; Nguyen TH; Yeap YY; Feeney OM; Williams HD; Benameur H; Pouton CW; Porter CJ
Mol Pharm; 2014 Nov; 11(11):4069-83. PubMed ID: 25265395
[TBL] [Abstract][Full Text] [Related]
13. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats.
Dahan A; Hoffman A
Eur J Pharm Biopharm; 2007 Aug; 67(1):96-105. PubMed ID: 17329087
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous lipolysis/permeation in vitro model, for the estimation of bioavailability of lipid based drug delivery systems.
Bibi HA; Holm R; Bauer-Brandl A
Eur J Pharm Biopharm; 2017 Aug; 117():300-307. PubMed ID: 28478159
[TBL] [Abstract][Full Text] [Related]
15. The influence on the oral bioavailability of solubilized and suspended drug in a lipid nanoparticle formulation: In vitro and in vivo evaluation.
Elbrink K; Van Hees S; Roelant D; Loomans T; Holm R; Kiekens F
Eur J Pharm Biopharm; 2022 Oct; 179():1-10. PubMed ID: 36031014
[TBL] [Abstract][Full Text] [Related]
16. Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant.
Bu P; Ji Y; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
Eur J Pharm Sci; 2017 Mar; 99():350-360. PubMed ID: 28024890
[TBL] [Abstract][Full Text] [Related]
17. Enabling superior drug loading in lipid-based formulations with lipophilic salts for a brick dust molecule: Exploration of lipophilic counterions and in vitro-in vivo evaluation.
Sirvi A; Jadhav K; Sangamwar AT
Int J Pharm; 2024 May; 656():124108. PubMed ID: 38604540
[TBL] [Abstract][Full Text] [Related]
18. Silica-lipid hybrid (SLH) versus non-lipid formulations for optimising the dose-dependent oral absorption of celecoxib.
Tan A; Davey AK; Prestidge CA
Pharm Res; 2011 Sep; 28(9):2273-87. PubMed ID: 21560021
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS).
Thomas N; Holm R; Müllertz A; Rades T
J Control Release; 2012 May; 160(1):25-32. PubMed ID: 22405903
[TBL] [Abstract][Full Text] [Related]
20. Using in vitro lipolysis and SPECT/CT in vivo imaging to understand oral absorption of fenofibrate from lipid-based drug delivery systems.
Tran T; Bønløkke P; Rodríguez-Rodríguez C; Nosrati Z; Esquinas PL; Borkar N; Plum J; Strindberg S; Karagiozov S; Rades T; Müllertz A; Saatchi K; Häfeli UO
J Control Release; 2020 Jan; 317():375-384. PubMed ID: 31765705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
